CASP2 and breast cancer: Although results from the mass spectrometry indicated a relatively low caspase-2 mRNA-binding affinity, we chose this candidate because TRIM25 has previously been reported as a key determinant of breast cancer metastasis [26], suggesting that it could also exert a tumorigenic role in colon carcinoma.